What is the most recent earnings date for RXO stock?
RXO INC (RXO) last reported earnings on 2/6/2026.
NYSE:RXO • US74982T1034
Past quarterly earnings results for RXO INC (RXO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.07 | -0.04 | -79.64% | -216.67% | 1.469B | 1.502B | -2.20% | -11.88% |
| Q3 2025 | 0.01 | 0.04 | -72.30% | -80.00% | 1.421B | 1.447B | -1.80% | 36.63% |
| Q2 2025 | 0.04 | 0.02 | 101.04% | 33.33% | 1.419B | 1.454B | -2.41% | 52.58% |
| Q1 2025 | -0.03 | -0.02 | -59.87% | - | 1.433B | 1.509B | -5.04% | 56.96% |
| Q4 2024 | 0.06 | 0.06 | 2.42% | - | 1.667B | 1.681B | -0.83% | 70.45% |
| Q3 2024 | 0.05 | 0.04 | 14.54% | - | 1.04B | 985.31M | 5.55% | 6.56% |
| Q2 2024 | 0.03 | 0.02 | 23.76% | -62.50% | 930M | 943.49M | -1.43% | -3.43% |
| Q1 2024 | -0.03 | -0.04 | 21.32% | -127.27% | 913M | 938.77M | -2.75% | -9.60% |
| Q4 2023 | 0.06 | 0.04 | 49.75% | -78.57% | 978M | 1.006B | -2.78% | -12.68% |
| Q3 2023 | 0.05 | 0.01 | 401.57% | -79.37% | 976M | 966.51M | 0.98% | -14.24% |
| Q2 2023 | 0.08 | 0.08 | -3.40% | - | 963M | 1.02B | -5.59% | -21.45% |
| Q1 2023 | 0.11 | 0.07 | 58.00% | - | 1.01B | 1.079B | -6.39% | -23.02% |
| Q4 2022 | 0.28 | 0.23 | 19.59% | - | 1.12B | 1.191B | -5.96% | -76.11% |
| Q3 2022 | 0.24 | - | - | 1.138B | 1.154B | -1.39% | - | |
| Q2 2022 | - | - | 1.226B | - | 11.56% | |||
| Q1 2022 | - | - | 1.312B | - | 23.19% | |||
| Q4 2021 | - | - | 4.689B | - | - | |||
| Q2 2021 | - | - | 1.099B | - | - | |||
| Q1 2021 | - | - | 1.065B | - | - |
Notes
RXO INC (RXO) last reported earnings on 2/6/2026.
RXO INC (RXO) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, RXO INC (RXO) has beaten EPS estimates in 1 out of 4 releases.